Formula E, officially the ABB FIA Formula E ... as well as strengthen cybersecurity. Google Cloud's Vertex AI platform and Gemini models will be pivotal in enhancing driver performance analysis.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The vision for X Games' future under new CEO Jeremy Bloom includes sports betting, AI judging, fantasy sports and the debut ...

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Notably, Vertex Pharmaceuticals (NASDAQ: VRTX), which focuses on developing treatments for rare diseases, has significantly outpaced both its biotechnology peers and the S&P 500 since early 2022.

From the outset, the guitar icon made no secret of the fact that the 1991 track held special meaning, having written it as a ...

Vertex Pharmaceuticals' suzetrigine showed lackluster Phase II results, but I still see potential in the non-addictive pain management market given the opioid crisis. Vertex's dominance in the ...

"With the Nile thing it really had the ‘Chic’ [sound], and I wanted to do my best Bernard Edwards impersonation!" ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...